Glaukos GKOS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Corneal Health | $89.16M+11.0% | $86.37M+7.7% | $83.76M+3.9% | $81.11M+1.8% | $80.33M+2.5% | |
| Glaucoma | $462.19M+42.6% | $421.07M+38.8% | $386.06M+38.0% | $351.85M+34.3% | $324.19M+30.7% | |
| Revenue by Geography | ||||||
| Non Us | $139.03M+18.8% | $132.4M+16.8% | $127.21M+18.4% | $121.78M+17.8% | $117.05M+18.2% | |
| US | $412.32M+43.4% | $375.04M+38.9% | $342.61M+35.5% | $311.18M+30.6% | $287.48M+26.4% | |
| PP&E (Net) by Geography | ||||||
| Non Us | $845K— | $742K— | $684K— | —— | —— | |
| US | $447.6M— | $432.08M— | $416.75M— | —— | —— | |
| Capital Expenditure by Geography | ||||||
| Non Us | $189K— | $99K— | —— | —— | —— | |
| US | $9.5M+32.4% | $7.57M+21.5% | $6.38M-33.4% | $6.19M-53.2% | $7.18M-55.5% | |
| D&A by Geography | ||||||
| Non Us | $49K+25.6% | $50K+42.9% | $47K+67.9% | $44K+120% | $39K+179% | |
| US | $41.61M+19.2% | $38.04M+6.8% | $34.62M-1.9% | $34.49M-0.7% | $34.93M+2.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
